MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-17-2026
Enochian Biosciences Historical Prices 2011-2026 | ENOB
Annual Historical Prices Enochian Biosciences
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.7 | 0.7 | 0.7 | 1.2 | 4.91 | 3.79 | 4.43 | 6.48 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 6.48 | 0.7 | 2.86 |
Historical Prices of other stocks in the Biotechnology industry
| Issuer | Historical Prices | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
MorphoSys AG
MOR
|
18.2 | - | 2.43 % | $ 254 M |  Germany |
 |
AbCellera Biologics
ABCL
|
3.22 | $ 3.55 | -0.28 % | $ 1.06 B |  Canada |
 |
Acorda Therapeutics
ACOR
|
13.5 | - | -24.86 % | $ 820 K |  USA |
 |
Acasti Pharma
ACST
|
3.37 | - | 4.01 % | $ 150 M | Canada |
 |
Advaxis
ADXS
|
0.31 | - | -9.65 % | $ 45.9 M | USA |
 |
AC Immune SA
ACIU
|
1.98 | $ 3.26 | 4.15 % | $ 229 M |  Schweiz |
 |
I-Mab
IMAB
|
0.68 | - | - | $ 866 M |  China |
 |
Aeglea BioTherapeutics
AGLE
|
12 | - | - | $ 1.01 B | USA |
 |
AgeX Therapeutics
AGE
|
13 | - | -10.17 % | $ 12.2 K | USA |
 |
Biophytis SA
BPTS
|
0.33 | - | -13.47 % | $ 169 M |  France |
 |
Albireo Pharma
ALBO
|
28.5 | - | -0.23 % | $ 916 M | USA |
 |
Aileron Therapeutics
ALRN
|
2.13 | - | 10.36 % | $ 9.8 M | USA |
 |
Aptorum Group Limited
APM
|
0.75 | $ 0.79 | 0.05 % | $ 4.31 M | China |
 |
ADC Therapeutics SA
ADCT
|
1.37 | $ 4.14 | -1.9 % | $ 105 M | Schweiz |
 |
Midatech Pharma plc
MTP
|
0.29 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Arcturus Therapeutics Holdings
ARCT
|
7.93 | $ 6.55 | -1.16 % | $ 179 M |  Israel |
 |
argenx SE
ARGX
|
615 | $ 711.17 | 1.12 % | $ 25 B |  Niderland |
 |
Alterity Therapeutics Limited
ATHE
|
0.58 | $ 3.43 | -4.99 % | $ 8.25 B |  Australia |
 |
Adverum Biotechnologies
ADVM
|
3.86 | - | - | $ 86.2 M | USA |
 |
Ascendis Pharma A/S
ASND
|
216 | $ 230.22 | -0.35 % | $ 5 B |  Danmark |
 |
BioCardia
BCDA
|
0.42 | $ 1.3 | 1.97 % | $ 27.5 M | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.3 | - | - | $ 26.5 M | USA |
 |
Applied Molecular Transport
AMTI
|
0.57 | - | - | $ 10.1 M | USA |
 |
Atea Pharmaceuticals
AVIR
|
5.23 | $ 6.12 | 1.16 % | $ 499 M | USA |
 |
Akero Therapeutics
AKRO
|
48.4 | - | - | $ 3.67 B | USA |
 |
Athersys
ATHX
|
0.9 | - | 3.77 % | $ 22.4 M | USA |
 |
Akouos
AKUS
|
5.34 | - | 0.23 % | $ 488 M | USA |
 |
Acer Therapeutics
ACER
|
0.77 | - | 2.71 % | $ 14 M | USA |
 |
ARCA biopharma
ABIO
|
28.8 | - | 1052.0 % | $ 415 M | USA |
 |
Allena Pharmaceuticals
ALNA
|
0.383 | - | 3.16 % | $ 1.9 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
1.45 | $ 3.43 | -4.19 % | $ 7.46 B | Israel |
 |
Aeterna Zentaris
AEZS
|
5.72 | - | 5.93 % | $ 314 M | Canada |
 |
Catalyst Biosciences
CBIO
|
11.2 | $ 11.3 | -2.46 % | $ 1.01 B | USA |
 |
AlloVir
ALVR
|
9.78 | - | 4.14 % | $ 49.1 M | USA |
 |
Anika Therapeutics
ANIK
|
25.4 | $ 14.59 | 1.6 % | $ 214 M | USA |
 |
Aptinyx
APTX
|
0.14 | - | -39.0 % | $ 4.57 M | USA |
 |
Aptose Biosciences
APTO
|
3.32 | - | -45.71 % | $ 1.2 M | Canada |
 |
CNS Pharmaceuticals
CNSP
|
1.36 | $ 2.4 | -2.04 % | $ 917 K | USA |
 |
AVEO Pharmaceuticals
AVEO
|
3.54 | - | - | $ 521 M | USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.5 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
2.51 | $ 2.63 | -0.57 % | $ 16.5 M | USA |
 |
Avenue Therapeutics
ATXI
|
0.42 | - | -52.27 % | $ 4.45 M | USA |
 |
Autolus Therapeutics plc
AUTL
|
1.66 | $ 1.52 | 0.33 % | $ 388 M | Britain |
 |
BioNTech SE
BNTX
|
91.2 | $ 94.73 | 4.62 % | $ 27.2 B | Germany |
 |
Athira Pharma
ATHA
|
0.42 | - | - | $ 269 M | USA |
 |
CureVac N.V.
CVAC
|
19.3 | - | - | $ 867 M | Germany |
 |
Aravive
ARAV
|
1.66 | - | -13.39 % | $ 1.45 M | USA |